FDA Approved: LEQEMBI — Original Application (Eisai Inc.)

View source ↗

Summary

FDA approved LEQEMBI (lecanemab) in an original BLA submission from Eisai Inc. for the treatment of Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LEQEMBI (lecanemab)

Snippet

ORIG AP for LEQEMBI (LECANEMAB)